KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Non-Current Assets: 2010-2025

Historic Non-Current Assets for Nektar Therapeutics (NKTR) over the last 15 years, with Sep 2025 value amounting to $20.0 million.

  • Nektar Therapeutics' Non-Current Assets fell 6.96% to $20.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.0 million, marking a year-over-year decrease of 6.96%. This contributed to the annual value of $42.6 million for FY2024, which is 36.79% down from last year.
  • As of Q3 2025, Nektar Therapeutics' Non-Current Assets stood at $20.0 million, which was down 4.66% from $21.0 million recorded in Q2 2025.
  • In the past 5 years, Nektar Therapeutics' Non-Current Assets registered a high of $357.5 million during Q1 2021, and its lowest value of $20.0 million during Q3 2025.
  • In the last 3 years, Nektar Therapeutics' Non-Current Assets had a median value of $43.2 million in 2023 and averaged $44.6 million.
  • As far as peak fluctuations go, Nektar Therapeutics' Non-Current Assets tumbled by 76.19% in 2023, and later climbed by 7.78% in 2024.
  • Quarterly analysis of 5 years shows Nektar Therapeutics' Non-Current Assets stood at $321.6 million in 2021, then crashed by 48.81% to $164.6 million in 2022, then crashed by 59.10% to $67.3 million in 2023, then crashed by 36.79% to $42.6 million in 2024, then dropped by 6.96% to $20.0 million in 2025.
  • Its Non-Current Assets was $20.0 million in Q3 2025, compared to $21.0 million in Q2 2025 and $26.3 million in Q1 2025.